STAAR Surgical Company  

(Public, NASDAQ:STAA)   Watch this stock  
Find more results for STAA
+0.30 (2.91%)
Real-time:   1:52PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 10.21 - 10.59
52 week 9.98 - 19.74
Open 10.38
Vol / Avg. 43,949.00/206,479.00
Mkt cap 395.48M
P/E     -
Div/yield     -
EPS -0.09
Shares 38.59M
Beta 0.20
Inst. own 83%
Oct 30, 2014
Q3 2014 STAAR Surgical Co Earnings Release (Estimated) Add to calendar
Oct 18, 2014
STAAR Surgical Co at American Academy of Ophthalmology's Annual Meeting
Sep 3, 2014
STAAR Surgical Co at Robert W. Baird & Co. Inc Health Care Conference
Aug 13, 2014
STAAR Surgical Co at Canaccord Genuity Growth Conference - Webcast
Aug 12, 2014
STAAR Surgical Co at Wedbush Securities Life Sciences Conference - Webcast
Jul 31, 2014
Q2 2014 STAAR Surgical Co Earnings Call - Webcast
Jul 31, 2014
Q2 2014 Staar Surgical Co Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '14) 2014
Net profit margin -8.92% 0.55%
Operating margin -6.93% 0.97%
EBITD margin - 3.95%
Return on average assets -11.15% 0.68%
Return on average equity -17.27% 1.13%
Employees 335 -
CDP Score - -


1911 Walker Ave
United States - Map
+1-626-3037902 (Phone)
+1-626-3032962 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye. The Company is the maker of lenses used worldwide in corrective or refractive surgery. It also makes lenses for use in surgery that treats cataracts. All of the lenses it makes are foldable, which permits the surgeon to insert them through a small incision during minimally invasive surgery. Refractive surgery corrects the types of visual disorders that glasses or contact lenses have traditionally treated. It refers to its lenses used in refractive surgery as implantable Collamer lenses (ICLs). The field of refractive surgery includes both lens-based procedures, using products like its ICL, and laser-based procedures like laser-assisted in-situ keratomileusis (LASIK). STAAR�s principal products are intraocular lens (IOLs) and ICLs used in ophthalmic surgery.

Officers and directors

Mark B. Logan Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Stephen P. Brown Chief Financial Officer, Vice President
Age: 54
Bio & Compensation  - Reuters
Hans-Martin Blickensdoerfer President, Europe, Middle East, Africa, Latin America
Age: 49
Bio & Compensation  - Reuters
Donald J. Todd President, Asia Pacific
Age: 61
Bio & Compensation  - Reuters
Deborah J. Andrews Chief Accounting Officer, Vice President
Age: 56
Bio & Compensation  - Reuters
Paul Hambrick Vice President - Global Operations
Age: 51
Bio & Compensation  - Reuters
Philippe Subrin Vice President - Switzerland Operations
Age: 50
Bio & Compensation  - Reuters
Samuel J. Gesten Vice President, General Counsel, Corporate Compliance Officer and Secretary
Age: 52
Bio & Compensation  - Reuters
Robin Hughes Vice President - Global Research and Development, Regulatory and Quality
Age: 50
Bio & Compensation  - Reuters
Donald Lee Fagen Vice President - North American Sales
Age: 60
Bio & Compensation  - Reuters